MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Neuroprotective drugs

NICE Guidance (see also drug specific guidance below)

NG42: Motor neurone disease: assessment and management, updated July 2019.

Riluzole is used to treat the amyotrophic lateral sclerosis form of motor neurone disease (MND)

 See here for shared care guideline for prescribing riluzole

Pack Price
56 tablet £336.70